THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...
Vous n'êtes pas connecté
Wegovy Granted Accelerated Approval as First GLP-1 Treatment for the Treatment of MASH Novo Nordisk’s Wegovy (semaglutide) has received US Food and Drug Administration (FDA) accelerated approval for the treatment of noncirrhotic metabolic...
THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...
THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...
THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...
EAST HANOVER, N.J., Sept. 30, 2025 -- Novartis announced today that Rhapsido® (remibrutinib) received US Food and Drug Administration (FDA)...
FDA Approves Rhapsido (remibrutinib) as the First Bruton’s Tyrosine Kinase Inhibitor for Chronic Spontaneous Urticaria Novartis has announced...
Zoetis Inc., a leading animal health company, announced that Dectomax─CA1 injectable is the first and only parasite control product to receive...
FRIDAY, Oct. 3, 2025 — A new low-cost version of the abortion pill mifepristone just received federal approval and it’s already stirring...
Key Takeaways The U.S. Food and Drug Administration approved a generic version of the abortion pill mifepristone Anti-abortion groups and some health...
WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...
WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...